BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16181651)

  • 1. Cyclopedic protein expression analysis of cultured canine mammary gland adenocarcinoma cells from six tumours.
    Nakagawa T; Watanabe M; Ohashi E; Uyama R; Takauji S; Mochizuki M; Nishimura R; Ogawa H; Sugano S; Sasaki N
    Res Vet Sci; 2006 Jun; 80(3):317-23. PubMed ID: 16181651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
    J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptors in canine mammary gland tumours.
    Sobczak-Filipiak M; Malicka E
    Pol J Vet Sci; 2002; 5(1):1-5. PubMed ID: 11944580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a pair of novel cloned tumour cell lines with or without metastatic potential from canine mammary adenocarcinoma.
    Murai K; Nakagawa T; Endo Y; Kamida A; Yoshida K; Mochizuki M; Nishimura R; Sasaki N
    Res Vet Sci; 2012 Aug; 93(1):468-72. PubMed ID: 21714977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
    Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
    J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
    Gama A; Gärtner F; Alves A; Schmitt F
    Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours.
    Kim JH; Yu CH; Yhee JY; Im KS; Sur JH
    J Comp Pathol; 2010; 142(2-3):177-86. PubMed ID: 19959182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of VEGF-C expression in canine mammary tumours.
    Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
    Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calreticulin expression in neoplastic versus normal dog mammary glands: a cDNA subtraction-based study.
    Okawa T; Kurio Y; Morimoto M; Hayashi T; Nakagawa T; Sasaki N; Okuda M; Mizuno T
    Res Vet Sci; 2012 Feb; 92(1):80-91. PubMed ID: 21126744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of beta-catenin, E-cadherin and APC in canine mammary tumors.
    Restucci B; Maiolino P; Martano M; Esposito G; De Filippis D; Borzacchiello G; Lo Muzio L
    Anticancer Res; 2007; 27(5A):3083-9. PubMed ID: 17970048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
    Nowak M; Madej JA; Podhorska-Okolow M; Dziegiel P
    In Vivo; 2008; 22(4):463-9. PubMed ID: 18712173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands.
    Klopfleisch R; Gruber AD
    Res Vet Sci; 2009 Aug; 87(1):91-6. PubMed ID: 19185891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesional function of canine mammary gland tumor cells expressing sialyl Lewis X.
    Nakagawa T; Endo Y; Watanabe M; Mochizuki M; Nishimura R; Sugano S; Sasaki N
    J Vet Med Sci; 2009 Sep; 71(9):1225-8. PubMed ID: 19801904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
    Faustino AM; van Garderen E; Schalken JA; Nederbragt H
    J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.